Navigation Links
Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients
Date:3/23/2009

style, and limited finances. For many patients in Kenya and other countries in Africa, patients are given a take-home packet of one to two week's medication where compliance cannot be monitored effectively. Non-compliance with the medication protocol can lead to the more dangerous Multidrug Resistant TB.

The goal of the MDOT Pilot Project was to determine if mobile technology would be an acceptable alternative for both the patient and the health care worker. As the results indicate, the participants expressed overall satisfaction with the MDOT Program. On a 5-point scale (5=strongly agree), health care workers rated the question of overall satisfaction with the program with a 5, patients and patient assistants ratings were 4.36 and 4.33 respectively. On the question of whether they agree that recording a patient taking their medication was a good option instead of meeting with someone in person, health care workers unanimously agreed with a rating of 5 and the patients and their assistants rated this question at 4.27 and 4.29, respectively.

Aaron Sundsmo, Danya's Regional Director for East Africa and on-site coordinator for the MDOT Pilot Project, will be joined by Dr. Andrew Suleh, who heads the TB program at Mbagathi District Hospital and provided medical oversight of the program, in presenting the findings at the East African Health and Scientific Conference. In addition to the Mbagathi District Hospital and the CDC's National Center for Health Marketing, Global Communication Team, other partners who supported the MDOT Pilot Project were Safaricom Limited (provided telecommunication services), Nokia Siemens Networks (provided Nokia mobile video phones), Mediae (donated video media messages), Voxiva (provided database software services), and EPOS Health Consultants (provided data collection support). Danya, in collaboration with RTI International, along with their public and private partners, will be seeking Phase II fundi
'/>"/>

SOURCE Danya International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. The College of New Rochelle School of Nursing Receives $50,000 Grant From the Verizon Foundation for Telenursing Pilot Program
2. Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services
3. Drug combination may be effective against deadly melanoma, pilot study shows
4. Rockefeller Universitys Center for Clinical and Translational Science funds 18 new pilot studies
5. Pilots May Face Greater Cancer Risk
6. Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease
7. NASA Conducts Pilot Cognition Studies
8. Washington Fire Firefighters Launch First of Its Kind Pilot Program on Health and Fitness
9. Anthem Blue Cross and Blue Shield Introduces International Medical Tourism Pilot Program
10. New Web Site Offers Shirts with Custom-embroidered Aviator Wings for Veteran Military Pilots, Supports Families of the Wounded Fund
11. Cleveland Clinic Pilots Microsoft HealthVault
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... that the loss of a key segment of DNA can ... to show that this kind of genetic alteration can cause ... , The study, led by Dr Sadaf Farooqi from the ... Trust Sanger Institute, looked at 300 children with severe obesity. ... types of mutation known as copy number variants (CNVs). CNVs ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... pivotal Phase 2b 003-A1 study, known as the ... heavily pre-treated relapsed and refractory multiple myeloma patients. ... Joint Symposium at the 51st annual meeting of ... Orleans. Enrollment in this trial is complete (n=269), ...
(Date:12/6/2009)... Sleep Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... problems with herbal or natural sleep aids from ... remedies for a good cause. The submissions will ... Sleep Aids ,Encyclopedia, by YOU, to be sold ... site will donate 100% of the proceeds ,from ...
(Date:12/5/2009)... significant scientific advances in the field of blood cancers, ... of how certain diseases progress in order to discover ... care. Research presented today at the 51st Annual Meeting ... therapies for managing multiple myeloma, the importance of advance ...
(Date:12/5/2009)... and myeloproliferative disorders are serious and often deadly ... Annual Meeting of the American Society of Hematology ... methods for patients suffering from acute promyelocytic leukemia, ... myelofibrosis that are based on a better understanding ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
... been known that countries with rapidly developing economies may ... overnutrition. People living in poverty experience diseases that result ... suffer from diseases that result from an abundance of ... Health (HSPH) and the University of Bristol have examined ...
... beating heart could be new screening tool , TUESDAY, Sept. ... the hearts of pre-diabetic people before either diabetes or heart ... at the University of Texas Southwestern Medical Center discovered the ... a new screening tool for people at risk for diabetes ...
... Md., Sept. 4 Martek,s life,sDHA(TM),from microalgae ... triglycerides in male,hypertriglyceridemic patients, according to a ... American Journal of Clinical Nutrition. In this ... EPA,(eicosapentaenoic acid), the other omega 3 commonly ...
... destroys,enamel, CHICAGO, Sept. 4 Fruit, yogurt, citric ... but improper,consumption and overuse may lead to devastating and ... an online member poll conducted by,the Academy of General ... common today compared to five years ago., To ...
... withhold drugs because of side effect concerns, study finds , ... safety of asthma drugs may prevent asthmatic children from getting ... to data released in the September issue of Pediatrics ... more concerned about the side effects of asthma medications than ...
... Marlabs, Inc. has been named by,the Brown-Wilson Group ... Top 10 BPO,healthcare revenue cycle management companies. ... outsourcing users and,decision makers globally, garnering over 21,000 ... CEO Siby Vadakekkara attributes the recognition to their,commitment ...
Other Medicine News:Health News:Income inequality associated with overnourishment and undernourishment in India 2Health News:Fat Builds Up in Hearts Before Diabetes Onset 2Health News:Study Demonstrates Martek's Algal DHA Oil Improves Blood Triglyceride Lipid Levels 2Health News:Study Demonstrates Martek's Algal DHA Oil Improves Blood Triglyceride Lipid Levels 3Health News:Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion 2Health News:Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion 3Health News:Parents' Worries Hamper Kids' Asthma Treatment 2Health News:Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies 2
(Date:12/4/2009)... (NYSE Amex: PIP ), a biodefense company developing ... the presentation of new data from the Company,s anthrax ... (rPA) based anthrax vaccine is structurally stable and potent ... including 55 degrees C. The data were presented ...
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, today ... and Chief Financial Officer. In this role, Mr. ... functions including finance, accounting, IT, IR, administration and human ... senior management team. ,, "One of my key ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented ... analysis of secondary end points of biochemical recurrence rate ... degarelix for injection) or monthly leuprolide in prostate cancer ... cancer patients who received FIRMAGON 240/80 mg/month had a ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 1November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 2November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 1New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 4Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 1Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 2Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 3
... Patent,Foundation ("PUBPAT") announced today that the U.S. Patent & ... by Gilead Sciences,that relate to the drug known generically ... battle against HIV/AIDS. Gilead markets TDF in,the United States ... of its ATRIPLA,combination product., Roughly 40 million people ...
... Genome Sciences,Inc. (Nasdaq: HGSI ) announced today that ... of its ACHIEVE clinical trials of Albuferon(R) (albinterferon,alfa-2b) for ... who have,been receiving the 1200-mcg dose will now receive ... by the studies, independent Data,Monitoring Committee (DMC). HGS continues ...
Other Medicine Technology:U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims 2Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 2Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 3Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 4Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: